- Honor Flight Means Everything to Navy Veteran with New Lease on Life - October 1, 2018
- Cardiovascular Research Day Features Science From Regional, National Researchers - September 26, 2018
- WKYT video - Dr. Aaron Hesselson and AHA's Lisa Edwards - July 10, 2018
- Doctors Changing Paths to Help the Opioid Crisis - June 14, 2018
- Some Heroes Slobber - Others Use Sophisticated Imaging Technology - April 25, 2018
- WKYT - University of Kentucky Releases Life-Saving Medication Combo for Breast Cancer Patients - April 16, 2018
- Study: Two Drugs Prevent Heart Failure in Breast Cancer Patients - March 12, 2018
- EverydayHealth.com - Study Reveals a Strategy to Reduce Heart Damage Linked to the Breast Cancer Drug Herceptin - March 12, 2018
- How Is An Olympian's Heart Different? - February 19, 2018
- Childhood Heart Patients Living Longer Into Adulthood - February 14, 2018
- 'Healthy Hearts for Women' Spotlights Cardiovascular Research - February 14, 2018
- New Treatments are Available for Drug-Resistant High Blood Pressure - January 19, 2018
- WKYT - UK Doctors Working Together to Stop Opioid Epidemic - October 19, 2017
Every year, 900 preventable deaths from cardiovascular disease occur in Kentucky’s 5th congressional district alone, according to one health statistic cited recently by University of Kentucky president Eli Capilouto at the unveiling of UK HealthCare’s new Cardiovascular Inpatient Unit, a 64-bed hub on the eighth floor of Pavilion A at the Chandler Hospital. UK calls the unit one of the largest of its type in the country with 32 intensive care beds and 32 progressive care beds. “It’s a powerful day for the University of Kentucky, but more so for the commonwealth,” Capilouto told the crowd.
Innovative research conducted by UK College of Design faculty Lindsey Fay and Allison Carll-White and their students is getting to the heart of health care design. The researchers in partnership with UK HealthCare recently completed a pre- and post-occupancy evaluation for the new eighth floor cardiovascular unit.
Clinical trials participant Tom Wall turned to the Gill Heart & Vascular Institute to get his high blood pressure in check.